News Sentiment

INM sentiment intelligence

InMed Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 22 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 1.64 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Deals and strategy

76/100 classification confidence.

Company focus 22

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend active

+5.1% over one week, +8.6% over four weeks, trend active, and below fair value.

Latest direct headline Neutral

ANI Pharmaceuticals' CFO Sold $285,000 in Stock After a 32% Run

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Deals and strategy 76/100 classification
One-week reaction 5.1% Price confirming higher
Trend fit Trend active 8.6% over four weeks
Fair value -67.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 20
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 22
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 7
TMX Newsfile 5
Investing News Network 2
The Motley Fool 1
MT Newswires 1
Moomoo 1
PR Newswire 1
InvestorsHub 1

Event Lens

What the news is about

Classified themes
Deals and strategy 10
Market update 9
Earnings 2
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-22 of 22